PreveCeutical Medical (TSE:PREV) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
PreveCeutical Medical’s subsidiary, BioGene Therapeutics, has appointed Dr. Mariya Georgieva as President to lead advancements in siRNA therapy for diabetes and obesity. Dr. Georgieva brings valuable experience from AstraZeneca, enhancing BioGene’s research capabilities in metabolic health and gene-based treatments.
For further insights into TSE:PREV stock, check out TipRanks’ Stock Analysis page.
